Northwestern Mutual Wealth Management Co. Sells 8,798 Shares of Danaher Corporation $DHR

Northwestern Mutual Wealth Management Co. lowered its holdings in Danaher Corporation (NYSE:DHR) by 14.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 52,638 shares of the conglomerate’s stock after selling 8,798 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Danaher were worth $12,050,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Elevated Capital Advisors LLC bought a new stake in shares of Danaher in the fourth quarter valued at approximately $26,000. JPL Wealth Management LLC bought a new stake in shares of Danaher in the third quarter valued at approximately $25,000. WFA of San Diego LLC bought a new stake in shares of Danaher in the second quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher in the third quarter valued at approximately $27,000. Finally, MidAtlantic Capital Management Inc. bought a new stake in shares of Danaher in the fourth quarter valued at approximately $33,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

DHR stock opened at $180.07 on Tuesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The stock has a market cap of $127.45 billion, a PE ratio of 34.83, a P/E/G ratio of 2.44 and a beta of 0.81. The firm has a 50 day simple moving average of $181.91 and a two-hundred day simple moving average of $207.20.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the company earned $1.88 EPS. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, analysts predict that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on DHR shares. UBS Group reduced their price objective on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Robert W. Baird reduced their price objective on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research note on Friday, April 17th. The Goldman Sachs Group reduced their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Monday, April 13th. Finally, Royal Bank Of Canada started coverage on shares of Danaher in a research note on Thursday, May 14th. They set an “outperform” rating and a $200.00 price objective for the company. Nineteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $238.24.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.